The final analysis of the U.K. trial showed that the vaccine was 96.4% effective against "mild, moderate, and severe disease caused by the original COVID-19 strain.
Vaccine efficacy was 86.3% against the fast-spreading U.K. variant (B.1.1.7/501Y.V1). Overall vaccine efficacy was 89.7%.
Vaccine efficacy was 86.3% against the fast-spreading U.K. variant (B.1.1.7/501Y.V1). Overall vaccine efficacy was 89.7%.
Хочешь хороших денег – умей выжидать